Rating History for Reata Pharmaceuticals (RETA) by Barclays

More Stocks Rated by Barclays | Latest Ratings for RETA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2023 Carter Gould Downgrade Equalweight
(Overweight)		 172.00
(N/A)		 167.19
(172.36)		 3.09% Details